Clinical Trial Update: Study of rhPro-UK in Patients With Acute Ischaemic Stroke in 4.5 Hours After Stroke Onset(PROST) [Phase 3]

View source ↗

Summary

Phase 3 trial of rhPro-UK in acute ischaemic stroke completed; no detailed results provided in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischaemic Stroke

Drugs mentioned

• rhPro-UK (recombinant human pro-urokinase)

Snippet

Sponsor: Tasly Biopharmaceuticals Co., Ltd. | Conditions: Acute Ischaemic Stroke | Phase 3 | Status: COMPLETED